Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?

Journal of Inherited Metabolic Disease

Volumn 34, Issue 3, 2011, Pages 781-787

  Giraldo, Pilar ^a,b,c,d   Capablo, Jose Luis ^a,c,d   Alfonso, Pilar ^a,b,c   Garcia Rodriguez, Beatriz ^a   Latre, Paz ^d   Irun, Pilar ^b,c,e   De Cabezon, Alicia Saenz ^a,c   Pocovi, Miguel ^b,c,d,e  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d FEETEG   (Spain)

^e UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL FEATURE; CONCENTRATION LOSS; CONTROLLED STUDY; DISEASE REGISTRY; ENZYME REPLACEMENT; EPILEPSY; FEMALE; GAUCHER DISEASE; GAUCHER DISEASE TYPE 1; GENE MUTATION; GENOTYPE; HEALTH SURVEY; HEARING LOSS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PHYSICIAN; PRESCHOOL CHILD; RELATIVE; SACCADIC EYE MOVEMENT; SCHOOL CHILD; SEX DIFFERENCE; SPAIN; STRABISMUS; TREMOR;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; GAUCHER DISEASE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREVALENCE; YOUNG ADULT;

EID: 79959776893     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9298-4     Document Type: Article

References (24)

1. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 351:1972-7 (Pubitemid 39447138)
2. Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P (2007) Spanish Gaucher's Disease Registry. Mutation analysis and genotype/ phenotype relationships of Gaucher disease patients in Spain. J Hum Genet 52:391-6 (Pubitemid 46669310)
3. Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3635-68
4. Capablo JL, de Cabezón SA, Fraile J, Alfonso P, Pocoví M, Giraldo P (2008) Neurological evaluation of Gaucher disease patients diagnosed as type 1. J Neurol Neurosurg Psychiatry 79:219-22 (Pubitemid 351236563)
5. Clark LN, Ross BM, Wang Y et al (2007) Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69:1270-7 (Pubitemid 47429028)
6. Farrer MJ, Williams LN, Algom AA et al (2009) Glucosidase-beta variations and Lewy body disorders. Parkinsonism Relat Disord 15:414-6
7. Giraldo P, Capablo JL, Alfonso P, Latre P, García B, Pocoví M (2008) Grupo Español sobre Enfermedad de Gaucher. Neurological manifestations in patients with Gaucher disease and in their relatives. Med Clin Barc 131:175-9
8. Giraldo P, Pocoví M, Pérez-Calvo J, Rubio-Félix D, Giralt M (2000) Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics. Haematologica 85:792-9
9. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of Parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353-57
10. Goker-Alpan O, Schiffmann R, La Marca ME, Nussbaum RL, McInerney-Leo A, Sidransky E (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937-40 (Pubitemid 40007255)
11. Halperin A, Elstein D, Zimran A (2006) Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 36:426-8 (Pubitemid 43776190)
12. Halperin A, Elstein D, Zimran A (2007) Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease? Acta Neurol Scand 115:275-8
13. Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L (2009) Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 452:87-9
14. Kono S, Shirakawa K, Ouchi Y et al (2007) Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier. J Neurol Sci 252:181-4 (Pubitemid 46048643)
15. Mitsui J, Mizuta I, Toyoda A et al (2009) Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66:571-6
16. Pastores GM, Barnett NL, Bathan P, Kolodny EH (2003) A neurological symptom survey of patients with type 1 Gaucher disease. J Inherit Metab Dis 26:641-5 (Pubitemid 38008968)
17. Pastores GM, Weinreb NJ, Aerts H et al (2004) Therapeutic goals in the treatment of Gaucher disease. Semin Hematol 41(4 Suppl 5):4-14 (Pubitemid 39311677)
18. Pocovi M, Cenarro A, Civeira F et al (1998) Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypoalpha- lipoproteinaemia. Lancet 351:1919-23 (Pubitemid 28297448)
19. Rijk MC, Tzourio C, Breteler MMB et al (1997) Prevalence of parkinsonism and Parkinson's disease in Europe: the Europarkinson collaborative study. J Neurol Neurosurg Psychiatry 62:10-15 (Pubitemid 27047434)
20. Sánchez C. (2010) Impacto sociosanitario de las enfermedades neurológicas en España. Fundación Española de Enfermedades Neurológicas (FEEN): Disponible en: http:\\www. feeneurologia.com (December)
21. Sidransky E (2004) Gaucher disease: complexity in a«simple» disorder. Mol Genet Metab 83:6-15
22. Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361:1651-61
23. Tayebi N, Walker J, Stubblefield B et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104-9
24. Ziegler SG, Eblan MJ, Gutti U et al (2007) Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 91:195-200 (Pubitemid 46765177)